EGF and breast carcinoma: A previous study found that the hydrophobic cytoplasmic domain of NgBR binds farnesylated Ras and further promotes the plasma membrane accumulation of Ras, which is a critical step for the activation of the epidermal growth factor (EGF)‐stimulated Ras pathway in human breast cancer cells.69